MTIM
BVS icon

Marathon Trading Investment Management’s Bioventus BVS Stock Holding History

Marathon Trading Investment Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,841
Closed -$108K – 283
2024
Q2 		$108K Sell
18,841
-45,259
-71% -$248K 0.01% 208
2024
Q1 		$333K Buy
+64,100
New +$313K 0.03% 222

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marathon Trading Investment Management's BVS Position: Q3 2024 in Review

Marathon Trading Investment Management sold out of Bioventus (BVS) in Q3 2024, closing a stake of 18,841 shares — an estimated $108K sold.

Marathon Trading Investment Management first reported a position in BVS in Q1 2024 and held it in 2 quarters. The position peaked at $333K in Q1 2024. 138 funds tracked by Wall St. Rank hold BVS as of Q3 2024.

  • Marathon Trading Investment Management reported no remaining Bioventus position as of Q3 2024 after selling out during the quarter.
  • Marathon Trading Investment Management sold 18,841 Bioventus shares in Q3 2024, an estimated $108K.
  • Marathon Trading Investment Management first reported a position in Bioventus in Q1 2024 and held it in 2 quarters.
  • Marathon Trading Investment Management's Bioventus position peaked at $333K in Q1 2024.
  • 138 funds tracked by Wall St. Rank held Bioventus as of Q3 2024.

Based on Marathon Trading Investment Management's 13F filing for Q3 2024, filed 7 Nov 2024.